Thermo Fisher Scientific (MA, USA), WuXi Diagnostics (Shanghai, China) and Mayo Clinic (MN, USA) are collaborating to develop and validate a serology test for COVID-19.
Browsing: Thermo Fisher Scientific
Emergency use authorization for Thermo Fisher Scientific’s COVID-19 diagnostic test expanded by US FDA
The US FDA has expanded the emergency use authorization granted to Thermo Fisher Scientific’s (MA, USA) COVID-19 diagnostic test. The expansion could facilitate workflow flexibility and increase test throughput.
Thermo Fisher Scientific (MA, USA) and Janssen Biotech (PA, USA) have entered an agreement to co-develop an oncology companion diagnostic. The companion diagnostic will be designed to support global clinical trial enrolment.
Thermo Fisher Scientific (MA, USA) are set to acquire Qiagen (Hilden, Germany), a provider of molecular diagnostics and sample preparation technologies, in an $11.5 billion transaction.
Thermo Fisher Scientific (MA, USA) have announced the release of a new HPLC system as well as the launch of new chromatography data system software.
Biotechnology product development company, Thermo Fisher Scientific (MA, USA), have released two new digital reagent dispensers. The precise dispensing capabilities of the dispensers could minimize reagent loss.
Could new software make it possible to accurately measure highly concentrated samples without dilution?
Thermo Fisher Scientific (MA, USA) have released the Thermo Scientific NanoDrop QC software. The software could simplify sample quality control for industrial users and could help to save time during sample preparation.
Thermo Fisher Scientific (MA, USA) and Agilent Technologies (CA, USA) renew their commitment to the Instrument Control Exchange Program, which aims to improve workflow efficiency by allowing users to select hardware and software that most appropriately meet their application needs.
American biotechnology product development company, Thermo Fisher Scientific (MA, USA), has announced the official opening of a Customer Solution Center in Shanghai, China.
Advancing novel biomarker identification: Thermo Fisher Scientific collaborate with Owlstone Medical
Thermo Fisher Scientific (MA, USA) have announced a collaborative partnership with Owlstone Medical (Cambridge, UK). The partnership will work towards the advancement of early cancer and disease diagnosis through the discovery and validation of novel biomarkers.